Initial Brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study

Initial Brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: feasibility study

INTRODUCTION: The objective of our study is to present the first Brazilian cryoablation experience in the treatment of low and intermediate risk localized prostate cancer using 3rd generation cryoablation and real-time biplanar transrectal ultrasonography. MATERIALS AND METHODS: Ten Brazilian patien...

Full description

Bibliographic Details
Main Authors:	Fernando J. Kim, Michael A. Cerqueira, Jose C. Almeida, Alexandre Pompeo, David Sehrt, Jose M. Calheiros, Fernando A. Martins, Wilson R. Molina
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2012-10-01
Series:	International Brazilian Journal of Urology
Subjects:	Cryoablation Prostatic Neoplasms PSA
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382012000500006

Similar Items

Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer
by: Christopher J. Diblasio, et al.
Published: (2008-08-01)

PROSTATE CRYOABLATION
by: A. V. Govorov, et al.
Published: (2014-07-01)

PROSTATE CRYOABLATION
by: A. V. Govorov, et al.
Published: (2014-07-01)

Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
by: Simon Robinson, et al.

Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01)

Focal cryosurgical ablation of the prostate: a single institute’s perspective
by: Hale Zachary, et al.
Published: (2013-01-01)

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
by: Kerri Beckmann, et al.
Published: (2019-08-01)

Salvage prostate cryoablation for recurrent localized prostate cancer after radiotherapy
by: Justin Ji-Yuen Siu, et al.
Published: (2016-12-01)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
by: Ulrika Rönningås, et al.
Published: (2019-07-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

The Accuracy of Increased Blood Concentration of Prostate-Specific Antigen to Prostate Malignancy
by: Daniel Mahendra Krisna, et al.
Published: (2018-04-01)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
by: Kan HC, et al.
Published: (2017-06-01)

High Serum Prostate Specific Antigen as A Risk Factor for Moderate-Severe Prostate Inflammation in Patient with Benign Prostatic Hyperplasia
by: Gede Wirya K Duarsa, et al.
Published: (2015-12-01)

High Serum Prostate Specific Antigen as A Risk Factor for Moderate-Severe Prostate Inflammation in Patient with Benign Prostatic Hyperplasia
by: Gede Wirya K Duarsa, et al.
Published: (2015-12-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

The novel prostate cancer antigen 3 (PCA3) biomarker
by: Andreas Bourdoumis, et al.
Published: (2010-12-01)

PSA screening for prostate cancer
by: Marcus V. Sadi

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
by: R. Jeffrey Karnes, et al.
Published: (2018-08-01)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
by: Narisa Dewi Maulany Darwis, et al.
Published: (2020-03-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
by: Martina Maggi, et al.
Published: (2021-04-01)

Investigation of correlations between different prostate-specific antigen forms and clinical and morphological characteristics of a tumor process in patients with prostate cancer
by: N. S. Sergeeva, et al.
Published: (2015-06-01)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

The Cancer
by: Rodrigo Donalisio da Silva, et al.
Published: (2015-02-01)

The Management of the Patient with Elevated Prostate Specific Antigen and a Negative Initial Prostate Biopsy
by: Vida A.O., et al.
Published: (2015-03-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study
by: Salvatore M. Bruno, et al.
Published: (2021-05-01)

Expressions of MVD, VEGF, Ki67 in Residual Prostate Cancer after Cryoablation
by: Yong Li, et al.
Published: (2011-03-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
by: O. Üçer, et al.
Published: (2017-06-01)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
by: Tobias Nordström, et al.
Published: (2017-10-01)

A study of biological determinants of serum prostate specific antigen level in prostatic adenocarcinoma with normal, borderline, and high serum PSA levels
by: Anu Sumi Issac, et al.
Published: (2014-01-01)

Differences in prostate cancer detection between Canadian and Saudi populations
by: O.Z. Al-Abdin, et al.
Published: (2013-01-01)

Differences in prostate cancer detection between Canadian and Saudi populations
by: O.Z. Al-Abdin, et al.
Published: (2013-06-01)

Controversies in Prostate Cancer Screening: is the Prostate Specific Antigen useful?
by: Pablo Yago Giménez, et al.
Published: (2019-12-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Prostate Specific Antigen. Current clinical application and future prospects
by: Katerina Duskova, et al.
Published: (2015-03-01)

Modern approaches for antiandrogen-resistant prostate cancer therapy
by: Felix Voinea, et al.
Published: (2021-04-01)

Association between preoperative prostate-specific antigen levels and mortality in high- and intermediate-grade prostate cancer patients who received radical prostatectomy: Findings from the SEER database
by: Joshua Ikuemonisan, et al.
Published: (2021-06-01)